PATENT CLAIM ANALYSIS

Application Number: 15768101
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "009700"]

Abstract:
A prophylactic and therapeutic agent for Rett Syndrome (RTT) is provided, a pharmaceutical composition comprising ghrelin and a pharmaceutically acceptable carrier and a prophylactic and therapeutic agent for RTT comprising a therapeutically effective amount of ghrelin. The side chain of serine at the 3rd position of ghrelin is modified with octanoic acid.

Claim (Index 2):
The pharmaceutical composition according to  claim 1  wherein the side chain of serine at the 3rd position of ghrelin is modified with octanoic acid.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 91.0
- Lexical Diversity: 1.46154
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12134707', '15950877', '15251880', '15663039', '12239229']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7374044152216721
- 35 USC 102 Novelty (BERT): 0.4826631161268369
- Combined Prediction Score: 0.7119302853121886
- Mean Citation Score: 167.111554
- Max Citation Score: 186.19244
- Similarity Product: 137.6935129223585

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test